Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Mark Your Calendars: 4 Biotechs Facing FDA Decision Dates in May 2017

Here are four biotech companies with Prescription Drug User Fee Act (PDUFA) dates in May 2017 as the U.S. Food and Drug Administration reviews New Drug Applications.

Read More »

AstraZeneca Dumps Two Drugs From Pipeline

As AstraZeneca faces declining revenue in 2017 from the loss of patents and the challenge of generic drugs, the company culled two drugs from its pipeline.

Read More »

Hello World

Hello world

Read More »

South Korea fines Novartis $49 million over kickbacks

South Korea fined Swiss drugmaker Novartis 55.1 billion won ($48.80 million) for offering doctors kickbacks to recommend the company’s drugs.

Read More »

Merck cholesterol drug Vytorin faces competition from Impax, Teva generics

Merck & Co.’s cholesterol-reducing drug Vytorin faces competition for the first time ever after two companies announced progress on their generic versions of a drug that generated more than $1 billion in 2016 sales.

Read More »

Messing with school operate? Term paper aid remedy to suit your needs!

Messing with school operate? Term paper aid remedy to suit your needs! Out of time? Burnt down your work deadlines? No tips for a typically reasonable report? We now have ready a whole lot for you!

Read More »

Messing with school operate? Term paper aid remedy to suit your needs!

Messing with school operate? Term paper aid remedy to suit your needs! Out of time? Burnt down your work deadlines? No tips for a typically reasonable report? We now have ready a whole lot for you!

Read More »

Anthem moving ahead on 2018 Obamacare insurance plans

Anthem Inc., which has 1.1 million customers in individual Obamacare plans, said it is moving ahead with its 2018 insurance filings but telling state regulators that it could increase premiums sharply and exit some markets.

Read More »

Finance chief quits drugmaker Teva

Teva Pharmaceutical Industries’ finance chief Eyal Desheh will step down, the second top official to resign from the Israel-based company during 2017.

Read More »

New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors

Prevencio Inc. announced the publication of data which demonstrates that a simple, new blood test is more accurate than evaluating commonly used risk factors in determining whether a person will have a heart attack, stroke or major cardiac event. Researchers believe the data, published in the American Journal of Cardiology (AJC), could revolutionize how doctors identify patients – not only higher-risk patients who need aggressive treatment, but also lower-risk patients who could avoid expensive and invasive procedures.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2018 Focus: Top 50 Pharma, Company of the Year and more!

Subscribe

Ad Right Bottom